iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Down 73.8% in April

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 1,095 shares, a decrease of 73.8% from the March 31st total of 4,185 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average daily trading volume, of 2,257 shares, the short-interest ratio is currently 0.5 days.

iShares Health Innovation Active ETF Stock Performance

Shares of BMED traded down $0.20 during trading hours on Friday, reaching $28.20. 1,178 shares of the company traded hands, compared to its average volume of 4,504. The stock’s fifty day moving average is $29.39 and its 200 day moving average is $29.77. The stock has a market cap of $10.15 million, a P/E ratio of 24.91 and a beta of 0.84. iShares Health Innovation Active ETF has a 1-year low of $23.23 and a 1-year high of $32.19.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new position in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF as of its most recent SEC filing.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.